aminoglutethimide has been researched along with medroxyprogesterone acetate in 41 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (58.54) | 18.7374 |
1990's | 12 (29.27) | 18.2507 |
2000's | 1 (2.44) | 29.6817 |
2010's | 4 (9.76) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Abe, K | 1 |
Clavel, M | 1 |
Focan, C | 1 |
Namer, M | 1 |
Bezwoda, WR | 1 |
Biakhov, MIu; Meshcheriakova, NG; Vasiuta, NIu; Voznyĭ, EK | 1 |
Bye, A; Cranny, A; Daly, PA; Feely, J; Halpenny, O | 1 |
Berger, U; Coombes, RC; McClelland, RA; Miller, LS; Powles, TJ | 1 |
Di Lauro, L; Lazzaro, B; Lopez, M; Papaldo, P | 1 |
Samonigg, H | 1 |
Enomoto, K; Fukutomi, T; Ikeda, T; Ishibiki, K; Isobe, Y; Kikuyama, S; Kubota, T; Nakamura, A; Nishiumi, T; Shimada, A | 1 |
Amalfitano, TG; Chumas, JC; Mann, WJ; Mazella, J; Stone, ML; Sun, B; Tseng, JK; Tseng, L; Wallach, RC | 1 |
Kvinssland, S; Lønning, PE; Ueland, PM | 1 |
Blossey, HC; Kleeberg, U; Nagel, GA; Wander, HE | 1 |
Manni, A | 1 |
Jonat, W; Maass, H | 1 |
Blossey, HC; Essers, U; Kleeberg, UR; Nagel, GA; Wander, HE | 1 |
Petru, E; Schmähl, D | 1 |
Kvinnsland, S; Lönning, PE; Lundgren, S; Wiedemann, G | 1 |
Canney, PA; Griffiths, T; Latief, TN; Mould, JJ; Priestman, TJ; Spooner, D | 1 |
Blijham, GH; Mellink, WA; Meulenberg, PM; Van Deijk, WA | 1 |
Cremer, P; Kruse, B; Kuhn, W; Nagel, GA; Seidel, D; Teichmann, AT; Wander, HE; Wieland, H | 1 |
Kaiser, R; Schulz, KD | 1 |
Blossey, HC; Nagel, GA; Wander, HE | 1 |
Ingle, JN | 1 |
Battelli, T; Ginnetti, A; Guistini, L; Manocchi, P; Mattioli, R | 1 |
Carlström, K; Döberl, A; Pousette, A; Rannevik, G; Wilking, N | 1 |
Kauppila, A | 1 |
Garbrecht, M; Kleeberg, UR; Müllerleile, U; Pompecki, R; Treidler, J | 1 |
Blossey, HC; Kleeberg, U; Köbberling, J; Nagel, GA; Wander, HE | 1 |
Evans, CA; Kennedy, TG | 1 |
Espié, M | 2 |
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Ferri, L; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Omodei Zorini, C | 1 |
Ahern, J; Iveson, TJ; Smith, IE | 1 |
Ayme, Y; Carton, M; Daban, A; Delozier, T; Fargeot, P; Fumoleau, P; Garcia-Giralt, E; Gorins, A; Guerin, D; Guerin, R | 1 |
6 review(s) available for aminoglutethimide and medroxyprogesterone acetate
Article | Year |
---|---|
[Hormone therapy of neoplasms].
Topics: Adenoma, Islet Cell; Aminoglutethimide; Breast Neoplasms; Female; Fluoxymesterone; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Pancreatic Neoplasms; Prostatic Neoplasms; Tamoxifen | 1991 |
Management of breast cancer with bone metastases.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Estrogens; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms, Hormone-Dependent; Palliative Care; Survival Rate | 1991 |
[Adjuvant hormone therapy of primary breast cancer. Review of the literature].
Topics: Amenorrhea; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen | 1991 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Bromocriptine; Dose-Response Relationship, Drug; Estrogen Antagonists; Female; Forecasting; Humans; Hydroxyprogesterones; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Neoplasm Recurrence, Local; Ovarian Neoplasms; Progestins; Receptors, Steroid; Uterine Neoplasms | 1984 |
[Hormonal therapy of breast cancer].
Topics: Aminoglutethimide; Breast Neoplasms; Female; Gonadotropin-Releasing Hormone; Humans; Medroxyprogesterone Acetate; Ovariectomy; Tamoxifen | 1994 |
7 trial(s) available for aminoglutethimide and medroxyprogesterone acetate
Article | Year |
---|---|
Treatment of stage D2 prostatic cancer refractory to or relapsed following castration plus oestrogens. Comparison of aminoglutethimide plus hydrocortisone with medroxyprogesterone acetate plus hydrocortisone.
Topics: Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Combined Modality Therapy; Diethylstilbestrol; Humans; Hydrocortisone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Staging; Orchiectomy; Postoperative Period; Prostatic Neoplasms; Randomized Controlled Trials as Topic | 1990 |
Tamoxifen therapy of metastatic breast cancer.
Topics: Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Random Allocation; Tamoxifen | 1987 |
[Aminoglutethimide plus high-dose medroxyprogesterone acetate versus aminoglutethimide plus cortisone in therapy of metastasizing breast cancer. An AIO phase III study].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cortisone; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Random Allocation | 1987 |
Randomized trial comparing aminoglutethimide with high-dose medroxyprogesterone acetate in therapy for advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Clinical Trials as Topic; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Random Allocation; Tamoxifen; Time Factors | 1988 |
Additive hormonal therapy in women with advanced breast cancer.
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Clinical Trials as Topic; Danazol; Drug Therapy, Combination; Estrogens; Female; Gonadal Steroid Hormones; Gonadotropin-Releasing Hormone; Humans; Hypophysectomy; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Random Allocation; Tamoxifen | 1984 |
[2d and 3d line hormonal therapy in postmenopausal metastatic breast tumor. Comparison of medroxyprogesterone acetate and aminoglutethimide in tamoxifen-resistant patients].
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1994 |
Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Breast Neoplasms; Drug Resistance; Female; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Prospective Studies; Tamoxifen; Time Factors; Treatment Outcome | 1992 |
29 other study(ies) available for aminoglutethimide and medroxyprogesterone acetate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Reflexions on hormone therapy of cancer of the breast].
Topics: Aminoglutethimide; Androgens; Breast Neoplasms; Estrogens; Female; Humans; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Ovariectomy; Tamoxifen | 1991 |
[Hormonal control of disseminated breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Estrogen Antagonists; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Tamoxifen | 1990 |
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate.
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Administration Schedule; Drug Interactions; Drug Resistance; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Survival Rate | 1990 |
Immunocytochemical assay for estrogen receptor in patients with breast cancer: relationship to a biochemical assay and to outcome of therapy.
Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Dextrans; Female; Histocytochemistry; Humans; Immunoenzyme Techniques; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Prognosis; Receptors, Estrogen; Staining and Labeling; Tamoxifen | 1986 |
Hormonal treatment of disseminated male breast cancer.
Topics: Adult; Aminoglutethimide; Androgen Antagonists; Antineoplastic Agents; Breast Neoplasms; Castration; Cyproterone; Cyproterone Acetate; Estrogens; Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Recurrence, Local; Tamoxifen; Time Factors | 1985 |
[Value of hormone therapy in metastasizing breast cancer].
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasm Metastasis; Ovariectomy; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1985 |
Experimental combined hormone therapy on human breast carcinomas serially transplanted into nude mice.
Topics: Adult; Aminoglutethimide; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Estradiol; Female; Humans; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organ Size; Tamoxifen; Transplantation, Heterologous; Uterus | 1986 |
Endocrine aspects of human uterine sarcoma: a preliminary study.
Topics: Adult; Aged; Aminoglutethimide; Animals; Aromatase; Aromatase Inhibitors; Cells, Cultured; Estradiol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Mice; Mice, Nude; Middle Aged; Nandrolone; Neoplasm Transplantation; Progesterone; Receptors, Estrogen; Receptors, Progesterone; Sarcoma; Uterine Neoplasms | 1986 |
Aminoglutethimide as an inducer of microsomal enzymes. Part 1: Pharmacological aspects.
Topics: Aminoglutethimide; Antipyrine; Dexamethasone; Digitoxin; Drug Interactions; Enzyme Activation; Humans; Kinetics; Medroxyprogesterone; Medroxyprogesterone Acetate; Microsomes; Theophylline; Warfarin | 1986 |
Aminoglutethimide and medroxyprogesterone acetate in the treatment of patients with advanced breast cancer. A phase II study of the Association of Medical Oncology of the German Cancer Society (AIO).
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Drug Evaluation; Drug Synergism; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Neoplasm Metastasis; Pain | 1986 |
[Endocrine therapy of breast cancer].
Topics: Aminoglutethimide; Antibodies, Monoclonal; Breast Neoplasms; Combined Modality Therapy; Female; Hormones; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1987 |
On the role of additive hormone monotherapy with tamoxifen, medroxyprogesterone acetate and aminoglutethimide, in advanced breast cancer.
Topics: Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Combined Modality Therapy; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Tamoxifen | 1987 |
[Which hormone therapy should be used in advanced breast carcinoma in males?].
Topics: Adenocarcinoma; Aged; Aminoglutethimide; Axilla; Breast Neoplasms; Dexamethasone; Drug Evaluation; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Tamoxifen; Testolactone; Testosterone Congeners | 1988 |
Influence of aminoglutethimide on plasma levels of medroxyprogesterone acetate: its correlation with serum cortisol.
Topics: Aminoglutethimide; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Pilot Projects | 1985 |
[Changes in serum lipoproteins under hormonal therapy of breast carcinoma and other endocrine-dependent tumors].
Topics: Aminoglutethimide; Breast Neoplasms; Cholesterol; Cortisone; Drug Therapy, Combination; Female; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Neoplasm Metastasis; Neoplasms, Hormone-Dependent; Triglycerides | 1985 |
[Current status of drug treatment of endometrial carcinoma].
Topics: Aminoglutethimide; Antineoplastic Agents; Estrogen Antagonists; Female; Humans; Immunotherapy; Medroxyprogesterone; Medroxyprogesterone Acetate; Palliative Care; Patient Care Planning; Uterine Neoplasms | 1983 |
[Medroxyprogesterone acetate (MAP) and aminoglutethimide (AG) in metastatic breast carcinoma. Preliminary report on a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Topics: Adult; Aged; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis | 1982 |
[Medical treatment of the breast].
Topics: Adrenal Cortex Hormones; Aged; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Estrogen Antagonists; Female; Gonadal Steroid Hormones; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors | 1984 |
Inhibition of steroid sulfatase activity by danazol.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Culture Techniques; Danazol; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Estrogen Antagonists; Estrone; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnadienes; Tamoxifen | 1984 |
[Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma].
Topics: Adult; Aged; Alkaline Phosphatase; Aminoglutethimide; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoembryonic Antigen; Female; Hormones; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Metastasis; Prognosis | 1984 |
[Medroxyprogesterone acetate as glucocorticoid in combination with aminoglutethimide in the treatment of metastatic breast cancer].
Topics: Adrenocorticotropic Hormone; Aminoglutethimide; Antineoplastic Agents; Breast Neoplasms; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Medroxyprogesterone; Medroxyprogesterone Acetate | 1982 |
Blastocyst implantation in ovariectomized, adrenalectomized hamsters treated with inhibitors of steroidogenesis during the pre-implantation period.
Topics: Adrenalectomy; Aminoglutethimide; Animals; Blastocyst; Castration; Cricetinae; Cyanoketone; Embryo Implantation; Embryonic Development; Estradiol; Estrone; Female; Medroxyprogesterone; Medroxyprogesterone Acetate; Mesocricetus; Ovary; Pregnancy; Progesterone; Prostaglandins; Uterus | 1980 |
Megestrol acetate in advanced breast carcinoma.
Topics: Aminoglutethimide; Breast Neoplasms; Carcinoma; Clinical Trials as Topic; Cross-Over Studies; Female; Humans; Medroxyprogesterone Acetate; Megestrol; Megestrol Acetate; Postmenopause; Prospective Studies; Randomized Controlled Trials as Topic; Tamoxifen; Treatment Outcome | 1994 |
Response to third-line endocrine treatment for advanced breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Neoplasm Staging; Retrospective Studies; Treatment Outcome | 1993 |